Search results
Author(s):
Moritake Iguchi
,
Hiromichi Wada
,
Felipe Martínez
,
et al
Added:
1 year ago
Author(s):
Byoung Geol Choi
,
Seung-Woon Rha
,
Se Yeon Choi
,
et al
Added:
10 months ago
Author(s):
Varun Sundaram
Added:
5 days ago
ESC HF 25 - Safety outcomes from PRAISE-HFrEF show that glucagon-like peptide-1 receptor agonism (GLP-1 RA) treatment for heart failure with reduced ejection fraction (HFrEF) and obesity was not associated with increased risk of heart failure hospitalisation or mortality compared to placebo, with greater benefits observed in patients with higher BMI.Dr Varun Sundaram (Case Western Reserve…
View more
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
10 months ago
Author(s):
Frederick Raal
Added:
1 year ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104).
The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in…
View more
Author(s):
Simran Singh Parmar
,
Vasantha Muthuppalaniappan
,
Debasish Banerjee
Added:
1 year ago
Author(s):
Massimiliano Camilli
,
Luca Maggio
,
Lorenzo Tinti
,
et al
Added:
2 months ago
Author(s):
Martin Berger
,
Nikolaus Marx
,
Katharina Marx-Schütt
Added:
1 month ago
Author(s):
Anastasia Shchendrygina
,
Ilya Giverts
,
Mariya Tokmakova
,
et al
Added:
6 months ago
Author(s):
Cheng Keat Tan
,
David Bin-Chia Wu
,
Seh Yi Joseph Tan
,
et al
Added:
1 year ago